Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| BEAM THERAPEUTICS INC(BEAM) | 2,266,934 | 2,266,934 | 0 | 55,540 | 56,220 | 75.61% | +680 |
| PRIME MEDICINE INC(PRME) | 1,792,210 | 1,792,210 | 0 | 6,936 | 5,233 | 7.04% | -1,703 |
| LYELL IMMUNOPHARMA INC(LYEL) | 20,162,332 | 20,162,332 | 0 | 27,824 | 12,904 | 17.35% | -14,920 |